(Q34764665)

4 August 2017

1 reference

title

Leukotriene receptor antagonists in the treatment of asthma: an update (English)

1 reference

4 August 2017

0 references

Balzano G

1

1 reference

4 August 2017

Fuschillo S

series ordinal

2

1 reference

4 August 2017

Gaudiosi C

series ordinal

3

1 reference

4 August 2017

language of work or name

1 reference

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

57 Suppl 72

1 reference

4 August 2017

page(s)

16-19

1 reference

The discovery of the leukotrienes

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

7 January 2021

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

7 January 2021

Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S72.2.X

7 January 2021

10.1034/J.1398-9995.57.S72.2.X

Identifiers

DOI

1 reference

4 August 2017

1 reference